Side-by-side comparison

Retatrutide vs Mazdutide — Price & Profile Comparison

Retatrutide

Triple-Action Metabolic Compound

GLP-1 / metabolic research

vs

Mazdutide

Retatrutide
Mazdutide
Cheapest price
$24.00 /10mg
$70.00 /10mg
Vendors stocking
57
3
Regulatory status
Not FDA-approved (Phase III)
Not FDA-approved (Phase III)
Mol. weight
4,731 g/mol

The short answer

Retatrutide vs Mazdutide: which to choose

Retatrutide is the cheaper option — roughly $24 vs $70 for the lowest verified listing. Retatrutide is the more widely stocked of the two (57 vendors vs 3).

Research products are not for human use. Looking for clinician-supervised care instead? Retatrutide is investigational; compare currently available clinician-guided GLP-1 options.

Compare supervised options →

Price Comparison — 2026

Retatrutide

VendorPrice
Step One Ventures$24.00 /10mgBuy →
Puratek Peptides$26.99 /10mgBuy →
NextGen Peptides$28.50 /10mgBuy →
ZC Labs$29.33 /10mgBuy →
Alpha Peptides$29.66 /10mgBuy →
Elite Edge Biotech$33.00 /10mgBuy →

Mazdutide

VendorPrice
Hydro Research$114.75 /10mgBuy →

Vendors Carrying Both

3 vendors stock both Retatrutide and Mazdutide — convenient if you want to bundle an order.

PeakForm PeptidesRetatrutide: $55.00Mazdutide: $70.00Visit →
Hydro ResearchRetatrutide: $74.38Mazdutide: $114.75Visit →
Offline PeptidesRetatrutide: $39.80Mazdutide: $178.00Visit →

Safety Notes

Retatrutide

FDA: Not FDA-approved (Phase III)

Phase II showed strong efficacy/tolerability; GI side effects; novel mechanism; promising safety data

Mazdutide

FDA: Not FDA-approved (Phase III)

Phase III trials ongoing; GI side effects; dual agonist; promising efficacy and tolerability

Failed to fetch